Printed from https://ideas.repec.org/s/sae/medema8.html
Content
September 2010, Volume 30, Issue 5_suppl
- 20-34 The DECISIONS Study: A Nationwide Survey of United States Adults Regarding 9 Common Medical Decisions
by Brian J. Zikmund-Fisher & Mick P. Couper & Eleanor Singer & Carrie A. Levin & Floyd J. Fowler Jr. & Sonja Ziniel & Peter A. Ubel & Angela Fagerlin - 35-52 Patients’ Knowledge about 9 Common Health Conditions: The DECISIONS Survey
by Angela Fagerlin & Karen R. Sepucha & Mick P. Couper & Carrie A. Levin & Eleanor Singer & Brian J. Zikmund-Fisher - 53-64 Decision-Making Processes for Breast, Colorectal, and Prostate Cancer Screening: The DECISIONS Survey
by Richard M. Hoffman & Carmen L. Lewis & Michael P. Pignone & Mick P. Couper & Michael J. Barry & Joann G. Elmore & Carrie A. Levin & John Van Hoewyk & Brian J. Zikmund-Fisher - 65-76 Race, Ethnicity, and Shared Decision Making for Hyperlipidemia and Hypertension Treatment: The DECISIONS Survey
by Neda Ratanawongsa & Brian J. Zikmund-Fisher & Mick P. Couper & John Van Hoewyk & Neil R. Powe - 77-84 How Does Feeling Informed Relate to Being Informed? The DECISIONS Survey
by Karen R. Sepucha & Angela Fagerlin & Mick P. Couper & Carrie A. Levin & Eleanor Singer & Brian J. Zikmund-Fisher - 85-95 Deficits and Variations in Patients’ Experience with Making 9 Common Medical Decisions: The DECISIONS Survey
by Brian J. Zikmund-Fisher & Mick P. Couper & Eleanor Singer & Peter A. Ubel & Sonja Ziniel & Floyd J. Fowler Jr. & Carrie A. Levin & Angela Fagerlin - 96-105 Perceived Risk of Cancer and Patient Reports of Participation in Decisions about Screening: The DECISIONS Study
by Amanda J. Dillard & Mick P. Couper & Brian J. Zikmund-Fisher - 106-114 Use of the Internet and Ratings of Information Sources for Medical Decisions: Results from the DECISIONS Survey
by Mick P. Couper & Eleanor Singer & Carrie A. Levin & Floyd J. Fowler Jr. & Angela Fagerlin & Brian J. Zikmund-Fisher
July 2010, Volume 30, Issue 4
- 1-13 A Method for Understanding Some Consequences of Bringing Patient-Generated Data into Health Care Delivery
by Duane A. Steward & Richard A. Hofler & Carey Thaldorf & David E. Milov - 14-27 Does Medicare Have an Implicit Cost-Effectiveness Threshold?
by James D. Chambers & Peter J. Neumann & Martin J. Buxton - 28-39 Effect of Adding a Values Clarification Exercise to a Decision Aid on Heart Disease Prevention: A Randomized Trial
by Stacey L. Sheridan & Jennifer M. Griffith & Lindy Behrend & Ziya Gizlice & Jianwen Cai & Michael P. Pignone - 40-56 Is an Ounce of Prevention Worth a Pound of Cure? Comparing Demand for Public Prevention and Treatment Policies
by Ryan Bosworth & Trudy Ann Cameron & J.R. DeShazo - 57-63 Theoretical Foundation of Patient v. Population Preferences in Calculating QALYs
by Afschin Gandjour - 64-81 Decision Making with Regard to Antiviral Intervention during an Influenza Pandemic
by Eunha Shim & Gretchen B. Chapman & Alison P. Galvani - 420-421 Abstracts for Web-Only Articles
by N/A - 422-423 Adjuvant! and Other Prediction Models in the Clinical Encounter with Cancer Patients
by Anne M. Stiggelbout - 424-425 Appropriate Cohorts for Cost-Effectiveness Analysis: To Mix or Not to Mix?
by Karen M. Kuntz & Elisabeth Fenwick & Andrew Briggs - 426-437 Whose Costs and Benefits? Why Economic Evaluations Should Simulate Both Prevalent and All Future Incident Patient Cohorts
by Martin Hoyle & Rob Anderson - 438-443 Prevalence of Antibodies Associated with Herd Immunity: A New Indicator to Evaluate the Establishment of Herd Immunity and to Decide Immunization Strategies
by Pedro Plans - 444-452 Informed Choice Assistance for Women Making Uterine Fibroid Treatment Decisions: A Practical Clinical Trial
by Leif I. Solberg & Stephen E. Asche & Karen Sepucha & N. Marcus Thygeson & Joan E. Madden & Larry Morrissey & Karen K. Kraemer & Louise H. Anderson - 453-463 Economic Evaluation of the DiAMOND Randomized Trial: Cost and Outcomes of 2 Decision Aids for Mode of Delivery among Women with a Previous Cesarean Section
by Sandra Hollinghurst & Clare Emmett & Tim J. Peters & Helen Watson & Tom Fahey & Deirdre J. Murphy & Alan Montgomery - 464-473 Breast Cancer Patients’ Treatment Expectations after Exposure to the Decision Aid Program Adjuvant Online: The Influence of Numeracy
by Isaac M. Lipkus & Ellen Peters & Gretchen Kimmick & Vlayka Liotcheva & Paul Marcom - 474-483 Markov Decision Processes: A Tool for Sequential Decision Making under Uncertainty
by Oguzhan Alagoz & Heather Hsu & Andrew J. Schaefer & Mark S. Roberts - 484-498 Contrasting Two Frameworks for ROC Analysis of Ordinal Ratings
by Daryl E. Morris & Margaret Sullivan Pepe & William E. Barlow - 499-508 Bivariate Random Effects Meta-Analysis of Diagnostic Studies Using Generalized Linear Mixed Models
by Haitao Chu & Hongfei Guo & Yijie Zhou - 509-517 Lehmann Family of ROC Curves
by Mithat Gönen & Glenn Heller - 518-522 Effect of Background Case Characteristics on Decisions in the Delivery Room
by Ori Shen & Ron Rabinowitz & Ruth R. Geist & Eldar Shafir
May 2010, Volume 30, Issue 3
- 1-11 Forecasting Distribution of Body Mass Index in the United States: Is There More Room for Growth?
by Anirban Basu - 12-19 Time Lost by Driving Fast in the United States
by Donald A. Redelmeier & Ahmed M. Bayoumi - 20-22 Decision Modeling to Inform Decision Making: Seeing the Wood for the Trees
by Jonathan Karnon & Alan Brennan & Ron Akehurst - 300-300 Web-Only Articles
by N/A - 301-303 Comparative Effectiveness Research: Challenges for Medical Journals
by Harold C. Sox & Mark Helfand & Jeremy Grimshaw & Kay Dickersin & David Tovey & J. André Knottnerus & Peter Tugwell - 304-313 Uncertainty Assessment of Input Parameters for Economic Evaluation: Gauss’s Error Propagation, an Alternative to Established Methods
by Björn Stollenwerk & Stephanie Stock & Uwe Siebert & Karl W. Lauterbach & Rolf Holle - 314-319 The Adoption of Cost-Effectiveness Acceptability Curves in Cost-Utility Analyses
by Lisa M. Meckley & Dan Greenberg & Joshua T. Cohen & Peter J. Neumann - 320-327 A Bibliometric Review of Cost-Effectiveness Analyses in the Economic and Medical Literature: 1976-2006
by Dan Greenberg & Allison B. Rosen & Oren Wacht & Jennifer Palmer & Peter J. Neumann - 328-340 Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities
by Rena Conti & David L. Veenstra & Katrina Armstrong & Lawrence J. Lesko & Scott D. Grosse - 341-354 Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome
by Oliver Rivero-Arias & Melissa Ouellet & Alastair Gray & Jane Wolstenholme & Peter M. Rothwell & Ramon Luengo-Fernandez - 355-365 A Time Tradeoff Method for Eliciting Partner’s Quality of Life due to Patient’s Health States in Prostate Cancer
by Anirban Basu & William Dale & Arthur Elstein & David Meltzer - 366-379 Implementing Regulation Policy in Brazilian Health Care Regulation Centers
by Márcia Elizabeth Marinho da Silva & Eduardo R. Santos & Denis Borenstein - 380-387 A Discrete Event Simulation Model to Evaluate Operational Performance of a Colonoscopy Suite
by Bjorn Berg & Brian Denton & Heidi Nelson & Hari Balasubramanian & Ahmed Rahman & Angela Bailey & Keith Lindor - 388-397 Changes of Heart: The Switch-Value Method for Assessing Value Uncertainty
by Leslie K. John & Baruch Fischhoff - 398-408 Measuring Acceptability of Clinical Decision Rules: Validation of the Ottawa Acceptability of Decision Rules Instrument (OADRI) in Four Countries
by Jamie C. Brehaut & Ian D. Graham & Timothy J. Wood & Monica Taljaard & Debra Eagles & Alison Lott & Catherine Clement & Anne-Maree Kelly & Suzanne Mason & Arthur Kellerman & Ian G. Stiell - 409-414 Life Expectancy in Individuals With Type 2 Diabetes: Implications for Annuities
by Hermione C. Price & Philip M. Clarke & Alastair M. Gray & Rury R. Holman
March 2010, Volume 30, Issue 2
- 1-97 31st Annual Meeting of the Society of Medical Decision Making Abstracts
by N/A - 153-154 Thank You To Our Reviewers
by N/A - 155-162 Exploring the Research Decision Space: The Expected Value of Information for Sequential Research Designs
by Susan Griffin & Nicky J. Welton & Karl Claxton - 163-175 Bayesian Hierarchical Models for Cost-Effectiveness Analyses that Use Data from Cluster Randomized Trials
by Richard Grieve & Richard Nixon & Simon G. Thompson - 176-188 Increasing the Detection and Response to Adherence Problems with Cardiovascular Medication in Primary Care through Computerized Drug Management Systems: A Randomized Controlled Trial
by Robyn Tamblyn & Kristen Reidel & Allen Huang & Laurel Taylor & Nancy Winslade & Gillian Bartlett & Roland Grad & André Jacques & Martin Dawes & Pierre Larochelle & Alain Pinsonneault - 189-193 Can Female Adolescents Tell Whether They Will Test Positive for Chlamydia Infection?
by Wändi Bruine de Bruin & Julie S. Downs & Pamela Murray & Baruch Fischhoff - 194-205 Uncertainty and Patient Heterogeneity in Medical Decision Models
by Bas Groot Koerkamp & Milton C. Weinstein & Theo Stijnen & M.H. Heijenbrok-Kal & M.G. Myriam Hunink - 206-216 Patient Time Requirements for Anticoagulation Therapy with Warfarin
by Daniel E. Jonas & Betsy Bryant Shilliday & W. Russell Laundon & Michael Pignone - 217-223 Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing
by A. David Paltiel & Harold A. Pollack - 224-233 Eliciting Population Preferences for Mass Colorectal Cancer Screening Organization
by Maximilien Nayaradou & Célia Berchi & Olivier Dejardin & Guy Launoy - 234-245 Satisfaction with Care: A Measure of Quality of Care in Prostate Cancer Patients
by Ravishankar Jayadevappa & J. Sanford Schwartz & Sumedha Chhatre & Alan J. Wein & S. Bruce Malkowicz - 246-257 Are Providers More Likely to Contribute to Healthcare Disparities Under High Levels of Cognitive Load? How Features of the Healthcare Setting May Lead to Biases in Medical Decision Making
by Diana J. Burgess - 258-266 Nearest-Neighbor and Logistic Regression Analyses of Clinical and Heart Rate Characteristics in the Early Diagnosis of Neonatal Sepsis
by Yuping Xiao & M. Pamela Griffin & Douglas E. Lake & J. Randall Moorman - 267-274 Use of Nomograms for Personalized Decision-Analytic Recommendations
by Alex Z. Fu & Scott B. Cantor & Michael W. Kattan - 275-289 Markov Processes for the Prediction of Aircraft Noise Effects on Sleep
by Mathias Basner & Uwe Siebert - 290-295 Author Index for the 31st Annual Meeting of the Society of Medical Decision Making Abstracts
by N/A
January 2010, Volume 30, Issue 1
- 1-22 12th Biennial European Meeting of the Society for Medical Decision Making Abstracts
by N/A - 5-15 Comparison of 5 Health-Related Quality-of-Life Indexes Using Item Response Theory Analysis
by Dennis G. Fryback & Mari Palta & Dasha Cherepanov & Daniel Bolt & Jee-Seon Kim - 16-28 Capacity Constraints and Cost-Effectiveness: A Discrete Event Simulation for Drug-Eluting Stents
by Beate Jahn & Karl Peter Pfeiffer & Engelbert Theurl & Jean-Eric Tarride & Ron Goeree - 29-34 Improving Decision Making at the End of Life With Video Images
by Angelo E. Volandes & Michael J. Barry & Yuchiao Chang & Michael K. Paasche-Orlow - 35-44 The Challenge of Shared Decision Making Among Patients With Lower Literacy: A Framework for Research and Development
by Kirsten J. McCaffery & Sian K. Smith & Michael Wolf - 45-57 Patients’ Preferences for Treatment of Hepatitis C
by Liana Fraenkel & Diane Chodkowski & Joseph Lim & Guadalupe Garcia-Tsao - 58-67 Health Utility Bias: A Systematic Review and Meta-Analytic Evaluation
by Jason N. Doctor & Han Bleichrodt & H. Jill Lin - 68-75 Sample Size in Obesity Trials: Patient Perspective Versus Current Practice
by David B. Allison & Mai A. Elobeid & Mark B. Cope & David W. Brock & Myles S. Faith & Stephanie Vander Veur & Robert Berkowitz & Gary Cutter & Theresa McVie & Kishore M. Gadde & Gary D. Foster - 76-83 The Language of Prognostication in Intensive Care Units
by Douglas B. White & Ruth A. Engelberg & Marjorie D. Wenrich & Bernard Lo & J. Randall Curtis - 84-98 Estimating Progression Rates for Human Papillomavirus Infection From Epidemiological Data
by Mark Jit & Nigel Gay & Kate Soldan & Yoon Hong Choi & William John Edmunds - 99-112 The Association Between Individual Time Preferences and Health Maintenance Habits
by W. David Bradford - 113-122 An Equivalent Relative Utility Metric for Evaluating Screening Mammography
by Craig K. Abbey & Miguel P. Eckstein & John M. Boone - 123-131 Evaluation of Imputation Methods in Ovarian Tumor Diagnostic Models Using Generalized Linear Models and Support Vector Machines
by Ioannis Dimou & Ben Van Calster & Sabine Van Huffel & Dirk Timmerman & Michalis Zervakis - 132-142 A Maximum Likelihood Estimator of a Markov Model for Disease Activity in Crohn’s Disease and Ulcerative Colitis for Annually Aggregated Partial Observations
by Sixten Borg & Ulf Persson & Tine Jess & Ole Østergaard Thomsen & Tryggve Ljung & Lene Riis & Pia Munkholm - 143-143 Comment on Petrou and Kupek: Use Unadjusted HUI3 Scores, Not Adjusted Disutilities
by Louise B. Russell - 144-145 Author Index for the 12th Biennial European Meeting of the Society for Medical Decision Making Abstracts
by N/A
November 2009, Volume 29, Issue 6
- 1-2 On Transparency in Decision Analytic Models
by Nancy Neil - 3-5 Comparative Effectiveness: A Table of Expected Benefits and Harms
by Michael W. Kattan - 6-8 Comparative Effectiveness Research Through the Looking Glass
by Adrian Levy & Brian Harrigan & Karissa Johnston & Andrew Briggs - 9-11 Individualization at the Heart of Comparative Effectiveness Research: The Time for i-CER Has Come
by Anirban Basu - 12-13 Comparative Effectiveness Research and Cancer Screening in the United States and Europe
by David H. Howard - 14-15 Are We Equipped to Train the Future Comparative Effectiveness Research Workforce?
by Daniel Jonas & Karen Crotty - 641-641 Comparative Effectiveness Research
by Mark Helfand - 642-642 CER Essay Introduction
by Kathryn M. McDonald - 643-660 Dimensions of Design Space: A Decision-Theoretic Approach to Optimal Research Design
by Stefano Conti & Karl Claxton - 661-677 The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies
by Peter C. Austin - 678-689 The Cost-Effectiveness of an RCT to Establish Whether 5 or 10 Years of Bisphosphonate Treatment Is the Better Duration for Women With a Prior Fracture
by Matt D. Stevenson & Jeremy E. Oakley & Myfawny Lloyd Jones & Alan Brennan & Juliet E. Compston & Eugene V. McCloskey & Peter L. Selby - 690-706 Evaluating the Claim of Enhanced Persistence: The Case of Osteoporosis and Implications for Payers
by Christina M. L. Kelton & Margaret K. Pasquale - 707-715 Does One Size Fit All? Investigating Heterogeneity in Men’s Preferences for Benign Prostatic Hyperplasia Treatment Using Mixed Logit Analysis
by Barbara Eberth & Verity Watson & Mandy Ryan & Jenny Hughes & Gillian Barnett
September 2009, Volume 29, Issue 5
- 1-12 Using the Principles of Randomized Controlled Trial Design to Guide Test Evaluation
by Sarah J. Lord & Les Irwig & Patrick M. M. Bossuyt - 13-21 Proposals for a Phased Evaluation of Medical Tests
by Jeroen G. Lijmer & Mariska Leeflang & Patrick M. M. Bossuyt - 22-29 Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests: Uses and Limitations
by Thomas A. Trikalinos & Uwe Siebert & Joseph Lau - 30-38 Additional Patient Outcomes and Pathways in Evaluations of Testing
by Patrick M. M. Bossuyt & Kirsten McCaffery - 549-556 Effects of Categorizing Continuous Variables in Decision-Analytic Models
by Tanya G. K. Bentley & Milton C. Weinstein & Karen M. Kuntz - 557-569 Incorporating Herd Immunity Effects into Cohort Models of Vaccine Cost-Effectiveness
by Chris T. Bauch & Andrea M. Anonychuk & Thierry Van Effelterre & Ba' Z. Pham & Maraki Fikre Merid - 570-579 Planning Posttherapeutic Oncology Surveillance Visits Based on Individual Risk
by T. Filleron & A. Barrett & O. Ataman & A. Kramar - 580-589 Incorporating Extrinsic Goals Into Decision and Cost-Effectiveness Analyses
by Gordon B. Hazen & Alan Schwartz - 590-598 Development of Goal-Sensitive Health-Related Utility Assessment Procedures
by Alan Schwartz & Gordon B. Hazen & Ariel Leifer & Paul S. Heckerling - 599-605 The Influence of Treatment Effect Size on Willingness to Adopt a Therapy
by Scott K. Aberegg & James M. O'Brien Jr & Paneez Khoury & Roocha Patel & Hal R. Arkes - 606-618 Diagnostic Certainty as a Source of Medical Practice Variation in Coronary Heart Disease: Results from a Cross-National Experiment of Clinical Decision Making
by Karen E. Lutfey & Carol L. Link & Lisa D. Marceau & Richard W. Grant & Ann Adams & Sara Arber & Johannes Siegrist & Markus Bönte & Olaf von dem Knesebeck & John B. McKinlay - 619-633 The German Coronary Artery Disease Risk Screening Model: Development, Validation, and Application of a Decision-Analytic Model for Coronary Artery Disease Prevention with Statins
by Björn Stollenwerk & Andreas Gerber & Karl W. Lauterbach & Uwe Siebert - 634-635 Web Exclusive White Paper Series on Diagnostic Test Evaluation
by Mark Helfand
July 2009, Volume 29, Issue 4
- 409-411 Getting Down to Details in the Design and Use of Decision Aids
by Angela Fagerlin - 412-413 Modeling Bioterrorism and Disaster Preparedness: SMDM's Recommendations for Design and Reporting
by Gillian D. Sanders - 414-423 Evaluating the Capability and Cost of a Mass Influenza and Pneumococcal Vaccination Clinic via Computer Simulation
by Michael L. Washington - 424-437 Predicting Hospital Surge after a Large-Scale Anthrax Attack: A Model-Based Analysis of CDC's Cities Readiness Initiative Prophylaxis Recommendations
by Nathaniel Hupert & Daniel Wattson & Jason Cuomo & Eric Hollingsworth & Kristof Neukermans & Wei Xiong - 438-460 Recommendations for Modeling Disaster Responses in Public Health and Medicine: A Position Paper of the Society for Medical Decision Making
by Margaret L. Brandeau & Jessica H. McCoy & Nathaniel Hupert & Jon-Erik Holty & Dena M. Bravata - 461-467 Long-Term Health Outcomes of a Decision Aid: Data from a Randomized Trial of Adjuvant! in Women with Localized Breast Cancer
by Andrew J. Vickers & Elena B. Elkin & Pamela B. Peele & Maura Dickler & Laura A. Siminoff - 468-474 Should Clinicians Deliver Decision Aids? Further Exploration of the Statin Choice Randomized Trial Results
by Lesley A. Jones & Audrey J. Weymiller & Nilay Shah & Sandra C. Bryant & Teresa J. H. Christianson & Gordon H. Guyatt & Amiram Gafni & Steven A. Smith & Victor M. Montori - 475-482 Is There a Role for Decision Aids in Advanced Breast Cancer?
by Karen R. Sepucha & Elissa M. Ozanne & Ann H. Partridge & Beverly Moy - 483-490 Effect of Risk Communication Formats on Risk Perception Depending on Numeracy
by Carmen Keller & Michael Siegrist - 491-499 A Fair Test of the Fair Innings?
by Adam Oliver - 500-502 The Half-Cycle Correction: Banish Rather Than Explain It
by Jan J. Barendregt - 503-512 The Incorporation of Income and Leisure in Health State Valuations When the Measure Is Silent: An Empirical Inquiry into the Sound of Silence
by Werner B. F. Brouwer & Saskia Grootenboer & Pedram Sendi - 513-520 Construction of Health Preferences: A Comparison of Direct Value Assessment and Personal Narratives
by José H. Kerstholt & Fred van der Zwaard & Hans Bart & Anita Cremers - 521-531 Offering Chemotherapy and Hospice Jointly: One Solution to Hospice Underuse
by Talya Salz & Noel T. Brewer - 532-540 Quantitative Risk Stratification in Markov Chains with Limiting Conditional Distributions
by David C. Chan & Philip K. Pollett & Milton C. Weinstein - 541-541 Errata
by N/A
May 2009, Volume 29, Issue 3
- 273-281 How Far Do You Go? Efficient Searching for Indirect Evidence
by Neil Hawkins & David A. Scott & Beth Woods - 282-290 Missing Celiac Disease in Family Medicine: The Importance of Hypothesis Generation
by Olga Kostopoulou & Charlotte Devereaux-Walsh & Brendan C. Delaney - 291-303 Estimating Preference-Based Health Utilities Index Mark 3 Utility Scores for Childhood Conditions in England and Scotland
by Stavros Petrou & Emil Kupek - 304-316 A Hybrid Cohort Individual Sampling Natural History Model of Age-Related Macular Degeneration: Assessing the Cost-Effectiveness of Screening Using Probabilistic Calibration
by Jonathan Karnon & Carolyn Czoski-Murray & Kevin J. Smith & Christopher Brand - 317-319 Physicians' Anticipated Regret and Diagnostic Testing: Comment on Hozo and Djulbegovic, 2008
by Michael L. DeKay - 320-324 Will Insistence on Practicing Medicine According to Expected Utility Theory Lead to an Increase in Diagnostic Testing? Reply to DeKay's Commentary: Physicians' Anticipated Regret and Diagnostic Testing
by Iztok Hozo & Benjamin Djulbegovic - 325-333 Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure
by George Miller & Stephen Randolph & Emma Forkner & Brad Smith & Autumn Dawn Galbreath - 334-342 Valuing Health: Does Enriching a Scenario Lead to Higher Utilities?
by Yvette Peeters & Anne M. Stiggelbout - 343-350 Early Stopping Rules in Clinical Trials Based on Sequential Monitoring of Serious Adverse Events
by A. Kramar & C. Bascoul-Mollevi - 351-367 Optimizing the Start Time of Statin Therapy for Patients with Diabetes
by Brian T. Denton & Murat Kurt & Nilay D. Shah & Sandra C. Bryant & Steven A. Smith - 368-371 Natural Frequencies Help Older Adults and People with Low Numeracy to Evaluate Medical Screening Tests
by Mirta Galesic & Gerd Gigerenzer & Nils Straubinger - 372-376 The Effect of Erroneous Computer Interpretation of ECGs on Resident Decision Making
by William N. Southern & Julia Hope Arnsten - 377-379 The Hippocratic Oath, Effect Size, and Utility Theory
by Robert F. Bordley - 380-390 Weighing Harm in Therapeutic Decisions of Smear-Negative Pulmonary Tuberculosis
by Juan Moreira & Bettina Bisig & Petronille Muwawenimana & Paulin Basinga & Zeno Bisoffi & Frank Haegeman & Panduru Kishore & Jef Van den Ende - 391-403 Laypersons' Responses to the Communication of Uncertainty Regarding Cancer Risk Estimates
by Paul K. J. Han & William M. P. Klein & Thomas C. Lehman & Holly Massett & Simon C. Lee & Andrew N. Freedman
March 2009, Volume 29, Issue 2
- 157-166 Health Literacy and Cancer Risk Perception: Implications for Genomic Risk Communication
by Noel T. Brewer & Janice P. Tzeng & Sarah E. Lillie & Alrick S. Edwards & Jeffrey M. Peppercorn & Barbara K. Rimer - 167-174 Randomized Trial of Presenting Absolute v. Relative Risk Reduction in the Elicitation of Patient Values for Heart Disease Prevention With Conjoint Analysis
by Jennifer M. Griffith & Carmen L. Lewis & Sarah Hawley & Stacey L. Sheridan & Michael P. Pignone - 175-181 The Psychosocial Effect of Thoughts of Personal Mortality on Cardiac Risk Assessment
by Jamie Arndt & Matthew Vess & Cathy R. Cox & Jamie L. Goldenberg & Stephen Lagle - 182-192 Intertemporal Tradeoffs: Perceiving the Risk in the Benefits of Marijuana in a Prospective Study of Adolescents and Young Adults
by Julie H. Goldberg & Susan Millstein & Alan Schwartz & Bonnie Halpern-Felsher - 193-201 Anchoring-and-Adjustment Bias in Communication of Disease Risk
by Ibrahim Senay & Kimberly A. Kaphingst - 202-206 Computer and Internet Use in a Community Health Clinic Population
by Neeraja B. Peterson & Kathleen A. Dwyer & Shelagh A. Mulvaney - 207-216 Value for Money in Changing Clinical Practice: Should Decisions about Guidelines and Implementation Strategies Be Made Sequentially or Simultaneously?
by Ties Hoomans & Johan L. Severens & Silvia M. A. A. Evers & Andre J. H. A. Ament - 217-223 Competence of General Practitioners in Giving Advice about Changes in Lifestyle to Hypertensive Patients
by Adam Windak & Barbara Gryglewska & Tomasz Tomasik & Krzysztof Narkiewicz & Tomasz Grodzicki - 224-238 The Cost-Effectiveness of Screening for Hereditary Hemochromatosis in Germany: A Remodeling Study
by Wolf H. Rogowski - 239-246 Development of a Clinical Prediction Model to Calculate Patient Life Expectancy: The Measure of Actuarial Life Expectancy (MALE)
by M.G. Clarke & K.P. Kennedy & R.P. MacDonagh - 247-256 Validation of an Automated Safety Surveillance System with Prospective, Randomized Trial Data
by Michael E. Matheny & David A. Morrow & Lucila Ohno-Machado & Christopher P. Cannon & Marc S. Sabatine & Frederic S. Resnic - 257-266 Impact of the Scale Upper Anchor on Health State Preferences
by Joseph T. King Jr & Joel Tsevat & Mark S. Roberts
January 2009, Volume 29, Issue 1
- 1-5 Author Index for Abstracts
by N/A - 1-98 30th Annual Meeting of the Society for Medical Decision Making Abstracts
by N/A - 5-6 Thank You to Our Reviewers
by N/A - 7-14 A Randomized Study of Scleroderma Health State Values: A Picture Is Worth a Thousand Words, and Quite a Few Utilities
by Dinesh Khanna & Robert M. Kaplan & Mark H. Eckman & Ron D. Hays & Anthony C. Leonard & Shaari S. Ginsburg & Joel Tsevat - 15-22 What Would It Be Like for Me and for You? Judged Impact of Chronic Health Conditions on Happiness
by Emma Walsh & Peter Ayton - 23-32 Labor Market Productivity Costs for Caregivers of Children with Spina Bifida: A Population-Based Analysis
by John M. Tilford & Scott D. Grosse & Allen C. Goodman & Kemeng Li - 33-50 Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium
by Joke Bilcke & Pierre Van Damme & Philippe Beutels - 51-60 Cost-Effectiveness of Insuring the Uninsured: The Case of Korean American Children
by Judy Y. Chen & Sharon Swonger & Gerald Kominski & Honghu Liu & Ji Eun Lee & Allison Diamant - 61-68 Decisional Conflict in Patients and Their Physicians: A Dyadic Approach to Shared Decision Making
by Annie LeBlanc & David A. Kenny & Annette M. O'Connor & France Légaré - 69-81 Modifying ICD-9-CM Coding of Secondary Diagnoses to Improve Risk-Adjustment of Inpatient Mortality Rates
by Michael Pine & Harmon S. Jordan & Anne Elixhauser & Donald E. Fry & David C. Hoaglin & Barbara Jones & Roger Meimban & David Warner & Junius Gonzales - 82-90 Do Intraindividual Variation in Disease Progression and the Ensuing Tight Window of Opportunity Affect Estimation of Screening Benefits?
by Hendrik Koffijberg & Gabriel Rinkel & Erik Buskens - 91-103 Controlling for Drug Dose in Systematic Review and Meta-Analysis: A Case Study of the Effect of Antidepressant Dose
by Richard A. Hansen & Charity G. Moore & Stacie B. Dusetzina & Brian I. Leinwand & Gerald Gartlehner & Bradley N. Gaynes - 104-115 A Multiattribute Model for Evaluating the Benefit-Risk Profiles of Treatment Alternatives
by James C. Felli & Rebecca A. Noel & Patrizia A. Cavazzoni - 116-124 Incorporating Uncertainty Into Medical Decision Making: An Approach to Unexpected Test Results
by Matt T. Bianchi & Brian M. Alexander & Sydney S. Cash - 125-139 A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis
by François-Emery Cotté & Bruno Fautrel & Gérard De Pouvourville - 140-148 Improving Fast and Frugal Modeling in Relation to Regression Analysis: Test of 3 Models for Medical Decision Making
by Lars G. Backlund & Johan Bring & Ylva Skånér & Lars-Erik Strender & Henry Montgomery
November 2008, Volume 28, Issue 6
- 801-802 Judging the Success of Annual Scientific Meetings
by Joel Tsevat - 803-809 Cost-Effectiveness of Clopidogrel: Seeing through the Smoke
by Lee Goldman & Jean-Michel Gaspoz - 810-818 Family Practitioners' Diagnostic Decision-Making Processes Regarding Patients with Respiratory Tract Infections: An Observational Study
by Thomas Fischer & Susanne Fischer & Wolfgang Himmel & Michael M. Kochen & Eva Hummers-Pradier - 819-828 Quality-Adjusted Life Years Lost from Nonfatal Motor Vehicle Accident Injuries
by John A. Nyman & Nathan A. Barleen & Phatta Kirdruang - 829-833 Theories of Medical Decision Making and Health: An Evidence-Based Approach
by Valerie F. Reyna - 834-844 A Reasoned Action Approach to Health Promotion
by Martin Fishbein - 845-849 Decision Making in the Transtheoretical Model of Behavior Change
by James O. Prochaska - 850-865 A Theory of Medical Decision Making and Health: Fuzzy Trace Theory
by Valerie F. Reyna - 866-874 Health Decision Making: Lynchpin of Evidence-Based Practice
by Bonnie Spring - 875-887 Modeling HUI 2 Health State Preference Data Using a Nonparametric Bayesian Method
by Samer A. Kharroubi & Christopher McCabe - 888-898 Evaluation of the Treatment Tradeoff Method in Rectal Cancer Patients: Is Surgery Preference Related to Outcome Utilities?
by Ercolie R. Bossema & Corrie A. M. Marijnen & Monique C. M. Baas-Thijssen & Cock J. H. van de Velde & Anne M. Stiggelbout - 899-908 Measuring the Involvement of People with HIV in Treatment Decision Making Using the Control Preferences Scale
by Heidemarie Kremer & Gail Ironson - 909-916 A Procedure for Determining Whether a Simple Combination of Diagnostic Tests May Be Noninferior to the Theoretical Optimum Combination
by Hua Jin & Ying Lu - 917-925 Anxiety, Fear of Cancer, and Perceived Risk of Cancer following Lung Cancer Screening
by Margaret M. Byrne & Joel Weissfeld & Mark S. Roberts - 926-937 Oral Cyclophosphamide for Active Scleroderma Lung Disease: A Decision Analysis
by Dinesh Khanna & Daniel E. Furst & Philip J. Clements & Donald P. Tashkin & Mark H. Eckman - 938-942 Peer Review in Publication: Factors Associated with the Full-Length Publication of Studies Presented in Abstract Form at the Annual Meeting of the Society for Medical Decision Making
by Dan Greenberg & Oren Wacht & Joseph S. Pliskin
September 2008, Volume 28, Issue 5
- 621-638 Bivariate Random Effects Meta-Analysis of ROC Curves
by L.R. Arends & T.H. Hamza & J.C. van Houwelingen & M.H. Heijenbrok-Kal & M.G.M. Hunink & T. Stijnen - 639-649 Meta-Analysis of Diagnostic Studies: A Comparison of Random Intercept, Normal-Normal, and Binomial-Normal Bivariate Summary ROC Approaches
by Taye H. Hamza & Johannes B. Reitsma & Theo Stijnen - 650-667 Integration of Meta-analysis and Economic Decision Modeling for Evaluating Diagnostic Tests
by Alexander J. Sutton & Nicola J. Cooper & Steve Goodacre & Matthew Stevenson - 668-680 Predictors of Diagnostic Accuracy and Safe Management in Difficult Diagnostic Problems in Family Medicine
by Olga Kostopoulou & Jurriaan Oudhoff & Radhika Nath & Brendan C. Delaney & Craig W. Munro & Clare Harries & Roger Holder - 681-689 Effect of Guidelines on Primary Care Physician Use of PSA Screening: Results from the Community Tracking Study Physician Survey
by Carmen E. Guerra & Phyllis A. Gimotty & Judy A. Shea & José A. Pagán & J. Sanford Schwartz & Katrina Armstrong - 690-698 Lessons Learned by (from?) an Economist Working in Medical Decision Making
by Peter P. Wakker - 699-705 Beyond Shared Decision Making: An Expanded Typology of Medical Decisions
by Simon N. Whitney & Margaret Holmes-Rovner & Howard Brody & Carl Schneider & Laurence B. McCullough & Robert J. Volk & Amy L. McGuire - 706-712 The Half-Cycle Correction Explained: Two Alternative Pedagogical Approaches
by David M. J. Naimark & Michelle Bott & Murray Krahn - 713-722 The Role of Value for Money in Public Insurance Coverage Decisions for Drugs in Australia: A Retrospective Analysis 1994-2004
by Anthony H. Harris & Suzanne R. Hill & Geoffrey Chin & Jing Jing Li & Emily Walkom - 723-731 Assessing the Influence of Gestalt-Type Characteristics on Preferences Over Lifetime Health Profiles
by Adam Oliver - 732-750 Obtaining Utility Estimates of the Health Value of Commonly Prescribed Treatments for Asthma and Depression
by Maria Orlando Edelen & M. Audrey Burnam & Katherine E. Watkins & José J. Escarce & Haiden Huskamp & Howard H. Goldman & Gary Rachelefsky - 751-762 The Impact of Individualized Evidence-Based Decision Support on Aneurysm Patients' Decision Making, Ideals of Autonomy, and Quality of Life
by Anne M. Stiggelbout & Albert C. Molewijk & Wilma Otten & J. Hajo Van Bockel & Cornelis M. A. Bruijninckx & Ilse Van der Salm & Job Kievit - 763-772 Beyond Utilitarianism: A Method for Analyzing Competing Ethical Principles in a Decision Analysis of Liver Transplantation
by Michael L. Volk & Anna S. F. Lok & Peter A. Ubel & Sandeep Vijan - 773-780 ``Not Everyone Who Needs One Is Going to Get One'': The Influence of Medical Brokering on Patient Candidacy for Total Joint Arthroplasty
by Pamela L. Hudak & Pamela Grassau & Richard H. Glazier & Gillian Hawker & Hans Kreder & Peter Coyte & Nizar Mahomed & James G. Wright - 781-792 Applying Social Marketing in Health Care: Communicating Evidence to Change Consumer Behavior
by W. Douglas Evans & Lauren McCormack
July 2008, Volume 28, Issue 4
- 460-461 Budget Impact Analysis and Its Rational Basis
by Jørgen Hilden - 462-470 Quality Performance Measurement Using the Text of Electronic Medical Records
by Serguei Pakhomov & Susan Bjornsen & Penny Hanson & Steven Smith - 471-480 Development and Validation of a Risk Scoring Tool to Predict Respiratory Syncytial Virus Hospitalization in Premature Infants Born at 33 through 35 Completed Weeks of Gestation
by John S. Sampalis & Joanne Langley & Xavier Carbonell-Estrany & Bosco Paes & Karel O'Brien & Upton Allen & Ian Mitchell & José Figueras Aloy & Carmen Pedraz & Andrea F. Michaliszyn - 481-490 Calculation of Prevalence with Markov Models: Budget Impact Analysis of Thrombolysis for Stroke
by Javier Mar & MarÃa Sainz-Ezkerra & Erika Miranda-Serrano - 491-499 Estimating EuroQol EQ-5D Scores from Population Healthy Days Data
by Haomiao Jia & Erica I. Lubetkin - 500-510 Feasibility and Reliability of the Annual Profile Method for Deriving QALYs for Short-Term Health Conditions
by Mathieu F. Janssen & Erwin Birnie & Gouke Bonsel - 511-523 End-of-Life Medical Treatment Choices: Do Survival Chances and Out-of-Pocket Costs Matter?
by Li-Wei Chao & José A. Pagán & Beth J. Soldo